₹ 1,902.30
-2.20 (-0.12%)
S
Sun Pharmaceutical
₹ 1,902.30
Sun Pharmaceutical EPS Summary (consolidated)
The latest quarterly EPS of Sun Pharmaceutical as of Q2 Sep 2026 stands at ₹8.30. This is a 31.40% fall quarter on quarter and 36.15% fall same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹13.22. It missed the estimate by ₹4.91. For the FY2026 the EPS of Sun Pharmaceutical stands at ₹47.80. This is a 4.82% growth compared with FY2025.
Sun Pharmaceutical EPS
EPS by Peers

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science

D
Dr Reddys Laboratories
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

